The Study Of CT Scans and Echo Parameters in Patients With PAH - Full Text View

Sponsored by:	North Shore Long Island Jewish Health System
Information provided by:	North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:	NCT00625963

Purpose

Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patterns of the PAH disease processes.

Condition
Pulmonary Hypertension

Genetics Home Reference related topics: pulmonary arterial hypertension

MedlinePlus related topics: CT Scans High Blood Pressure Nuclear Scans Pulmonary Hypertension

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	The Study of CT Scan and Echocardiogram Parameters in Patients With Pulmonary Hypertension With Regards to Hemodynamics, Sleep Studies, and Various Laboratory Markers.

Further study details as provided by North Shore Long Island Jewish Health System:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	421
Study Start Date:	April 2007
Estimated Study Completion Date:	June 2008
Estimated Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts
I,A I=Pulmonary Hypertension Patients A=ILD patients with Pulmonary Hypertension Patients

Detailed Description:

The goal of our study is to correlate data from various non-invasive tests such as commuted tomographt (CT) imaging, echocardiogram, Pulmonary Function Tests, and other laboratory tests along with hemodynamic measurments from Right Heart Catherizations in these ILD patients with Pulmonary Hypertension, as well as all other pulmonary hypertension. The ultimate goal is to determine patterns of the PAH disease processes, as well as define optimal diagnostic modalities including in-hospital verses outpatient studies.

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Pulmonary Arterial Hypertension; Idiopathic Lung Disease

Criteria

Inclusion Criteria:

Pulmonary Hypersion;
ILD with Pulmonary Hypertension

Exclusion Criteria:

NON-PH

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00625963

Contacts

Contact: Arunabh Talwar, MD	516-465-5400	arunabh@nshs.edu
Contact: Patricia J Berkoski, MS, RRT	516-465-5400	arunabh@nshs.edu

Locations

United States, New York
North Shore-Long Island Jewish Health System	Recruiting
New Hyde Park, New York, United States, 11040
Contact: Arunabh Talwar, MD 516-465-5400 arunabh@nshs.edu
Contact: Patricia Berkoski, MS, RRT 516-465-5400 arunabh@nshs.edu
Principal Investigator: Arunabh Talwar, MD

Sponsors and Collaborators

North Shore Long Island Jewish Health System

Investigators

Principal Investigator:

Arunabh Talwar, MD

North Shore-LIJ Health System

More Information

Responsible Party:	North Shore-Long Island Jewish Health System ( Arunabh Talwar MD )
Study ID Numbers:	07.060
Study First Received:	February 20, 2008
Last Updated:	February 20, 2008
ClinicalTrials.gov Identifier:	NCT00625963
Health Authority:	United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:

Pulmonary Hypertension;
ILD;
CT Imaging;

Echocardiogram;
Hemodynamic measurements of RHC.
Pulmonary Function Tests

Study placed in the following topic categories:

Respiratory Tract Diseases
Hypertension, Pulmonary
Lung Diseases
Vascular Diseases
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009